Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04586335||Phase I||CYH33 + Olaparib||Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.||Recruiting||USA | AUS||1|
|NCT03842228||Phase I||Copanlisib + Durvalumab + Olaparib||Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations||Recruiting||USA||0|
|NCT05768139||Phase Ib/II||Fulvestrant + STX-478 STX-478||First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumor||Recruiting||USA||0|
|NCT05154487||Phase II||Alpelisib + Fulvestrant||A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer||Not yet recruiting||USA||0|